Can repackaging containers of commercially available hazardous drug oral liquids into prescription containers be assessed for risk?

Repackaging containers of commercially available hazardous drug oral liquids into prescription containers can indeed be assessed for risk, as indicated in the correct answer. This assessment is crucial to ensure that any risks associated with such activities are identified and appropriately managed.

In the context of USP 800 guidelines, which aim to promote the safe handling of hazardous drugs, a comprehensive risk assessment helps determine the suitability and safety of repackaging procedures. This includes evaluating the potential for contamination, the integrity of the drug, and the safety of the personnel involved in the repackaging process. By conducting a risk assessment, organizations can implement necessary controls and procedures to mitigate risks while still potentially allowing for the repackaging of hazardous drugs, contingent upon a thorough evaluation.

This practice acknowledges that while certain activities may pose inherent risks, they can often be carried out safely if properly managed. Therefore, assessing the risk allows for informed decision-making regarding the repackaging of these oral liquids.